These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7710186)

  • 1. New strategies in the treatment of systemic vasculitis.
    Jayne DR; Lockwood CM
    Ann Med Interne (Paris); 1994; 145(8):595-600. PubMed ID: 7710186
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose pooled immunoglobulin in the therapy of systemic vasculitis.
    Jayne DR; Lockwood CM
    Trans Assoc Am Physicians; 1991; 104():304-12. PubMed ID: 1845155
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal models of systemic vasculitis.
    Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
    J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to specific immunotherapy for systemic vasculitis.
    Lockwood CM
    Semin Neurol; 1994 Dec; 14(4):387-92. PubMed ID: 7709089
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy.
    Lockwood CM
    Clin Exp Immunol; 1996 May; 104 Suppl 1():77-82. PubMed ID: 8625549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary results of intravenous immunoglobulins in treating patients with vasculitis].
    Antonelli A; Agostini G; Agostini S
    Clin Ter; 1992 Sep; 141(9 Pt 2):33-6. PubMed ID: 1468195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic vasculitis treatment and monitoring update, 2008.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2008; 66(3):228-30. PubMed ID: 18937637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biologic therapies in the management of systemic vasculitis.
    Chan AT; Flossmann O; Mukhtyar C; Jayne DR; Luqmani RA
    Autoimmun Rev; 2006 Apr; 5(4):273-8. PubMed ID: 16697969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of patients with systemic vasculitis (review)].
    Nasonov EL; Shilkina NP; Baranov AA
    Ter Arkh; 1998; 70(11):53-8. PubMed ID: 9949462
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of vasculitis.
    Taylor HG; Samanta A
    Br J Clin Pharmacol; 1993 Feb; 35(2):93-104. PubMed ID: 8443041
    [No Abstract]   [Full Text] [Related]  

  • 14. Newer therapies for vasculitis.
    Hiemstra TF; Jayne D
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):379-89. PubMed ID: 19508945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of systemic vasculitis.
    Calabrese LH
    Neurol Clin; 1997 Nov; 15(4):973-91. PubMed ID: 9367976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
    Bosch X; Guilabert A; Espinosa G; Mirapeix E
    Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary systemic vasculitis.
    Day C; Savage C
    Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of an animal model of systemic vasculitis.
    Qasim FJ; Mathieson PW; Thiru S; Oliveira DB; Lockwood CM
    Adv Exp Med Biol; 1993; 336():133-7. PubMed ID: 8296602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of new drugs for intractable vasculitis--lipo-PGE1 and monoclonal antibody].
    Matsuda T; Hoshi K; Igarashi R; Ichikawa Y
    Nihon Rinsho; 1994 Aug; 52(8):2187-91. PubMed ID: 7933610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What place for the new biologics in the treatment of necrotising vasculitides.
    Jayne D
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S1-5. PubMed ID: 16859587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.